Bahrain to screen 6,000 children for blood disorders:
This article was originally published in Clinica
Executive Summary
Bahrain is to begin its annual screening project of children aged between 25-16 for hereditary blood disorders. The project, which targets sufferers of sickle cell anaemia, beta thalassemia and Glucose-6-Phosphate Dehydrogenase deficiency, is funded by the Bahrain Society for Hereditary Diseases to the tune of BD20,000 ($53,000) and organised in collaboration with the ministry of health. This is the sixth time that such a screening project has been undertaken in Bahrain and, on its completion in May 2004, a total of 36,000 children will have been tested.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.